We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

71 hedge funds and large institutions have $369M invested in Five Prime Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

157% more capital invested

Capital invested by funds: $144M → $369M (+$226M)

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

13% more funds holding

Funds holding: 63 → 71 (+8)

Holders
71
Holders Change
+8
Holders Change %
+12.7%
% of All Funds
1.89%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
18
Increased
26
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.77M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.23M
3
BFA
BlackRock Fund Advisors
California
+$5.45M
4
BIM
Bogle Investment Management
Massachusetts
+$3.12M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.87M

Top Sellers

1
O
OrbiMed
New York
-$12.6M
2
BI
BVF Inc
California
-$10.9M
3
Goldman Sachs
Goldman Sachs
New York
-$7.98M
4
QF
QVT Financial
New York
-$2.54M
5
NI
Numeric Investors
Massachusetts
-$540K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$61.9M +$2.48M +143,894 +7%
VVM
2
Versant Venture Management
California
$29.5M +$18.8M +1,092,152 New
TGHSA
3
TPG Group Holdings (SBS) Advisors
Texas
$28.4M – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$24.8M +$7.23M +419,882 +84%
BI
5
BVF Inc
California
$22.3M -$10.9M -635,568 -43%
EAM
6
Eventide Asset Management
Massachusetts
$21.2M +$179K +10,400 +1%
BFA
7
BlackRock Fund Advisors
California
$19.7M +$5.45M +316,886 +77%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$15.3M +$9.77M +567,400 New
QF
9
QVT Financial
New York
$13.5M -$2.54M -147,313 -23%
PI
10
Putnam Investments
Massachusetts
$12M – – –
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$11.3M +$2.87M +166,795 +67%
Millennium Management
12
Millennium Management
New York
$9.34M +$2.47M +143,339 +71%
SAM
13
Senzar Asset Management
New York
$8.98M +$588K +34,174 +11%
Vanguard Group
14
Vanguard Group
Pennsylvania
$8.41M +$95.9K +5,572 +2%
AIC
15
AWM Investment Company
New York
$8.1M +$5.16M +300,000 New
BIT
16
BlackRock Institutional Trust
California
$7.25M +$1.82M +105,851 +65%
State Street
17
State Street
Massachusetts
$5.62M +$329K +19,115 +10%
BIM
18
Bogle Investment Management
Massachusetts
$4.89M +$3.12M +181,118 New
Northern Trust
19
Northern Trust
Illinois
$4.47M -$30.2K -1,757 -1%
PA
20
Perceptive Advisors
New York
$4.19M +$90.5K +5,256 +4%
EAM
21
EverPoint Asset Management
Connecticut
$4.05M +$2.58M +150,000 New
Wells Fargo
22
Wells Fargo
California
$3.52M -$419K -24,357 -16%
RSCM
23
Rock Springs Capital Management
Maryland
$3.24M +$86.1K +5,000 +4%
BA
24
BlackRock Advisors
Delaware
$2.87M +$1.71M +99,260 +1,430%
MSA
25
Mason Street Advisors
Wisconsin
$2.65M -$164K -9,555 -9%
1
2 3 4

FPRX Hedge Fund Activity: Q4 2014 in Review

71 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2014, worth a combined $369M — up 157% from $144M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new FPRX positions and 8 closed out — a net gain of 10 holders — while 26 added to existing stakes and 15 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $9.77M. The largest seller was OrbiMed, exiting entirely with an estimated $12.6M sold.

  • 71 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2014, up from 63 in Q3 2014.
  • Funds reported $369M of Five Prime Therapeutics, Inc. stock for Q4 2014, up 157% quarter-over-quarter.
  • 18 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2014 and 8 closed out, a net change of +10 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q4 2014 was Point72 Asset Management, an estimated $9.77M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q4 2014 was OrbiMed, an estimated $12.6M sold.

Based on aggregated 13F filings for Q4 2014.